Table 1.

Comparison of general and baseline clinical characteristics between the two groups after matching.3+

Indicator	Control Group (n = 65)	Observation Group (n = 65)	Statistic	P-value
Age (years, $\overline{x}\pm s$)	42.8 ± 14.2	40.5 ± 13.1	t = 0.967	.335
Sex (Male/Female, n)	40/25	35/30	χ2χ2 = 0.782	.377
BMI (kg/m2, $\overline{x}\pm s$)	21.5 ± 3.4	20.8 ± 3.2	t = 1.201	.232
Disease Duration [years, M(Q1, Q3)]	5.2 (2.0, 9.5)	4.5 (1.8, 8.5)	Z = 1.023	.306
Admission CDAI Score (points, $\overline{x}\pm s$)	258.7 ± 52.3	245.6 ± 49.8	t = 1.456	.148
Daily Bowel Movement Frequency (times/day, $\overline{x}\pm s$)	6.3 ± 2.4	5.8 ± 2.1	t = 1.267	.208
Admission Albumin Level (g/L, $\overline{x}\pm s$)	32.1 ± 4.5	33.5 ± 4.6	t = 1.734	.085
Use of Biologics [n (%)]	30 (46.2)	26 (40.0)	χ2χ2 = 0.502	.479
Use of Corticosteroids [n (%)]	33 (50.8)	29 (44.6)	χ2χ2 = 0.492	.483
Complicated with Diabetes Mellitus [n (%)]	8 (12.3)	5 (7.7)	χ2χ2 = 0.773	.379
Smoking History [n (%)]	18 (27.7)	14 (21.5)	χ2χ2 = 0.656	.418